Novel Insertion Mutation in KCNJ5 Channel Produces Constitutive Aldosterone Release From H295R Cells
- PMID: 26340408
- PMCID: PMC5414677
- DOI: 10.1210/me.2015-1195
Novel Insertion Mutation in KCNJ5 Channel Produces Constitutive Aldosterone Release From H295R Cells
Abstract
Primary aldosteronism accounts for 5%-10% of hypertension and in a third of cases is caused by autonomous aldosterone production by adenomas (APA). Somatic mutations in the potassium channel encoded by KCNJ5 have been detected in surgically removed APAs. To better understand the role of these mutations, we resequenced the KCNJ5 channel in a large Australian primary aldosteronism cohort. KCNJ5 mutations were detected in 37 APAs (45% of the cohort), including previously reported E145Q (n = 3), G151R (n = 20), and L168R (n = 13) mutations. In addition, we found a novel 12-bp in-frame insertion mutation (c.414-425dupGCTTTCCTGTTC, A139_F142dup) that duplicates the AFLF sequence in the pore helix upstream of the selectivity filter. Expressed in Xenopus oocytes, the A139_F142dup mutation depolarized the oocytes and produced a G-protein-sensitive Na(+) current with altered K(+) selectivity and loss of inward rectification but retained Ba(2+) sensitivity. Transfected into H295R cells, A139_F142dup increased basal aldosterone release 2.3-fold over the wild type. This was not increased further by incubation with angiotensin II. Although the A139_F142dup mutant trafficked to the plasma membrane of H295R cells, it showed reduced tetramer stability and surface expression compared with the wild-type channel. This study confirms the frequency of somatic KCNJ5 mutations in APAs and the novel mutation identified (A139_F142dup) extend the phenotypic range of the known KCNJ5 APA mutations. Being located in the pore helix, it is upstream of the previously reported mutations and shares some features in common with selectivity filter mutants but additionally demonstrates insensitivity to angiotensin II and decreased channel stability.
Figures
Similar articles
-
A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.J Clin Endocrinol Metab. 2014 Sep;99(9):E1765-73. doi: 10.1210/jc.2014-1927. Epub 2014 Jul 24. J Clin Endocrinol Metab. 2014. PMID: 25057880 Free PMC article.
-
Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.Hypertension. 2014 Apr;63(4):783-9. doi: 10.1161/HYPERTENSIONAHA.113.02234. Epub 2014 Jan 13. Hypertension. 2014. PMID: 24420545
-
Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma.J Hypertens. 2012 Sep;30(9):1827-33. doi: 10.1097/HJH.0b013e328356139f. J Hypertens. 2012. PMID: 22743686
-
New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.Curr Opin Nephrol Hypertens. 2013 Mar;22(2):141-7. doi: 10.1097/MNH.0b013e32835cecf8. Curr Opin Nephrol Hypertens. 2013. PMID: 23318698 Review.
-
Role of KCNJ5 in familial and sporadic primary aldosteronism.Nat Rev Endocrinol. 2013 Feb;9(2):104-12. doi: 10.1038/nrendo.2012.230. Epub 2012 Dec 11. Nat Rev Endocrinol. 2013. PMID: 23229280 Review.
Cited by
-
Primary aldosteronism diagnostics: KCNJ5 mutations and hybrid steroid synthesis in aldosterone-producing adenomas.Gland Surg. 2020 Feb;9(1):3-13. doi: 10.21037/gs.2019.10.22. Gland Surg. 2020. PMID: 32206594 Free PMC article. Review.
-
Cardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronism.Front Endocrinol (Lausanne). 2023 Mar 6;14:1061704. doi: 10.3389/fendo.2023.1061704. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36950676 Free PMC article. Review.
-
Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.J Mol Endocrinol. 2016 Jul;57(1):1-11. doi: 10.1530/JME-15-0324. Epub 2016 Apr 20. J Mol Endocrinol. 2016. PMID: 27099398 Free PMC article.
-
Targeted disruption of the Kcnj5 gene in the female mouse lowers aldosterone levels.Clin Sci (Lond). 2018 Jan 16;132(1):145-156. doi: 10.1042/CS20171285. Print 2018 Jan 16. Clin Sci (Lond). 2018. PMID: 29222092 Free PMC article.
-
ROMK expression remains unaltered in a mouse model of familial hyperkalemic hypertension caused by the CUL3Δ403-459 mutation.Physiol Rep. 2016 Jul;4(13):e12850. doi: 10.14814/phy2.12850. Physiol Rep. 2016. PMID: 27378813 Free PMC article.
References
-
- Funder JW, Carey RM, Fardella C, et al. . Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93(9):3266–3281. - PubMed
-
- Mulatero P, Stowasser M, Loh KC, et al. . Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89(3):1045–1050. - PubMed
-
- Lenzini L, Rossi GP. The molecular basis of primary aldosteronism: from chimeric gene to channelopathy. Curr Opin Pharmacol. 2015;21(0):35–42. - PubMed
-
- Zheng F-F, Zhu L-M, Nie A-F, et al. . Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma. Hypertension. 2015;65(3):622–628. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
